Alzheimer's disease drug development pipeline: 2021
Abstract
The number of individuals worldwide with Alzheimer's disease (AD) is growing at a rapid rate. New treatments are urgently needed. We review the current pipeline of drugs in clinical trials for the treatment of AD.
This paper has been withdrawn.